Benchmarking the Pharma Industry’s HEOR Functions

This report provides pharmaceutical and biotech organizations an opportunity to benchmark their own Health Economics and Outcomes Research (HEOR) approaches against that of Top 50 Pharma companies. The report details best practices, common approaches, as well as explains alternative styles so companies can use these assessments as a yard stick against which to measure, modify, …

Benchmarking the Pharma Industry’s Medical Affairs Functions

Medical Affairs, as a function, sits at a crossroads in the pharmaceutical industry. The department isexpected to act as a bridge between the commercial and scientific arms of an organization. Medical Affairs is further tasked with being the conduit of information between the company and external stakeholders, bringing efficacy and safety data to the medical …

The Corporate Reputation of Pharma Industry – The Patient Perspective in 2015 – Global Edition

This report is based on the findings of a survey that was done between November 2015 – January 2016 exploring the views of 1,075 patient groups from 72 countries, and focusing on differing medical specialties. The report provides feedback on the corporate reputation of the pharma industry during 2015, as well as the performance of …

The Corporate Reputation of Pharma Industry – The Patient Perspective in 2015 – Europe Edition

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 797 patient groups based in the Europe (Western and Eastern) in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the European pharma industry during 2015, as well as the performance of …

The Corporate Reputation of Pharma Industry – The Patient Perspective in 2015 – Spain Edition

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 108 patient groups based in Spain in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the Spanish pharma industry during 2015, as well as the performance of 14 pharma companies for …

Global and Chinese Single-Use Bioreactors for Pharma Industry – 2017

The 'Global and Chinese Single-Use Bioreactors for Pharma Industry – 2017' is a professional and in-depth study on the current state of the global Single-Use Bioreactors for Pharma industry with a focus on the Chinese market. The report provides key statistics on the market status of the Single-Use Bioreactors for Pharma manufacturers and is a …

Global Automation Market in Biopharmaceutical Industry 2017-2021

About Automation in Biopharmaceutical Industry The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government …

Global Anti-counterfeit Packaging Market in Pharmaceutical Industry 2017-2021

About Anti-counterfeit Packaging in Pharmaceutical Industry Anti-counterfeit packaging is a process carried out to secure the packaging of products to reduce infringement. The demand for anti-counterfeit packaging in the pharmaceutical industry is increasing. With a growing initiative by technology vendors in the market, the pharmaceutical companies have an opportunity to fight against counterfeit issues. For …

Global Active Pharmaceutical Ingredients (API) Market Analysis & Trends – Industry Forecast to 2025

The Global Active Pharmaceutical Ingredients (API) Market is poised to grow at a CAGR of around 6.6% over the next decade to reach approximately $238.8 billion by 2025. Some of the prominent trends that the market is witnessing include, Growing Geriatric Population, Rapid growth in biopharmaceuticals sector and Technological Advancements in API Manufacturing. Based on …